| Year |
Citation |
Score |
| 2020 |
Liu Y, Mao C, Wang M, Liu N, Ouyang L, Liu S, Tang H, Cao Y, Liu S, Wang X, Xiao D, Chen C, Shi Y, Yan Q, Tao Y. Cancer progression is mediated by proline catabolism in non-small cell lung cancer. Oncogene. PMID 31911619 DOI: 10.1038/S41388-019-1151-5 |
0.301 |
|
| 2017 |
Jiang Y, Mao C, Yang R, Yan B, Shi Y, Liu X, Lai W, Liu Y, Wang X, Xiao D, Zhou H, Cheng Y, Yu F, Cao Y, Liu S, et al. EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes. Theranostics. 7: 3293-3305. PMID 28900510 DOI: 10.7150/Thno.19988 |
0.349 |
|
| 2016 |
He X, Yan B, Liu S, Jia J, Lai W, Xin X, Tang CE, Luo D, Tan T, Jiang Y, Shi Y, Liu Y, Xiao D, Chen L, Liu S, et al. Chromatin remodeling factor LSH drives cancer progression by suppressing the activity of fumarate hydratase. Cancer Research. PMID 27302170 DOI: 10.1158/0008-5472.Can-16-0268 |
0.498 |
|
| 2016 |
Jia J, Shi Y, Yan B, Xiao D, Lai W, Pan Y, Jiang Y, Chen L, Mao C, Zhou J, Xi S, Cao Y, Liu S, Tao Y. LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway. Oncotarget. PMID 27049829 DOI: 10.18632/Oncotarget.8465 |
0.478 |
|
| 2015 |
Jiang Y, Yan B, Lai W, Shi Y, Xiao D, Jia J, Liu S, Li H, Lu J, Li Z, Chen L, Chen X, Sun L, Muegge K, Cao Y, et al. Repression of Hox genes by LMP1 in nasopharyngeal carcinoma and modulation of glycolytic pathway genes by HoxC8. Oncogene. PMID 25745994 DOI: 10.1038/Onc.2015.53 |
0.472 |
|
| 2014 |
Liu S, Yan B, Lai W, Chen L, Xiao D, Xi S, Jiang Y, Dong X, An J, Chen X, Cao Y, Tao Y. As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect. Biochimica Et Biophysica Acta. 1839: 592-603. PMID 24859470 DOI: 10.1016/j.bbagrm.2014.05.017 |
0.476 |
|
| 2013 |
Xiao D, Yang D, Guo L, Lu W, Charpentier M, Yan B. Regulation of carboxylesterase-2 expression by p53 family proteins and enhanced anti-cancer activities among 5-fluorouracil, irinotecan and doxazolidine prodrug British Journal of Pharmacology. 168: 1989-1999. PMID 23373735 DOI: 10.1111/Bph.12125 |
0.509 |
|
| 2013 |
Xiao D, Shi D, Yang D, Barthel B, Koch TH, Yan B. Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs. Biochemical Pharmacology. 85: 439-47. PMID 23228697 DOI: 10.1016/J.Bcp.2012.11.026 |
0.507 |
|
| 2012 |
Xiao D, Chen YT, Yang D, Yan B. Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation. Biochemical Pharmacology. 84: 232-9. PMID 22513142 DOI: 10.1016/J.Bcp.2012.04.002 |
0.494 |
|
| 2012 |
Yang D, Yang J, Shi D, Xiao D, Chen YT, Black C, Deng R, Yan B. Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump. Journal of Lipid Research. 53: 529-39. PMID 22246918 DOI: 10.1194/Jlr.M014688 |
0.493 |
|
| 2009 |
You LG, Zhang KH, Zhang XA, Xie DH, Yang MF, Wang FH, Huang H, Wang XT, Xiao DX, Yan B. Diagnosis and treatment of epistaxis caused by non-traumatic pseudoaneurysms of carotid artery. Chinese Medical Journal. 122: 1955-7. PMID 19787867 |
0.333 |
|
| 2009 |
Jiang N, Xiao D, Zhang D, Sun N, Yan B, Zhu X. Negative roles of a novel nitrogen metabolite repression-related gene, TAR1, in laccase production and nitrate utilization by the basidiomycete Cryptococcus neoformans. Applied and Environmental Microbiology. 75: 6777-82. PMID 19734333 DOI: 10.1128/AEM.00708-09 |
0.447 |
|
| Show low-probability matches. |